INSUGEN 30/70 100IU

Distributor inventory

Treatment of diabetes mellitus (Type 1 and Type 2) to control blood glucose levels; may be used when a premixed insulin regimen is appropriate.

This premix contains 30% short-acting regular human insulin for mealtime glucose control and 70% intermediate-acting NPH insulin for basal control. It lowers blood glucose by increasing peripheral glucose uptake and reducing hepatic glucose production.

Inject subcutaneously only, as prescribed by a doctor (common sites: abdomen, thigh, upper arm; rotate sites). Typically given 30 minutes before meals due to the regular insulin component. Do not use intravenously; resuspend gently (roll) until uniformly cloudy before use; check label/strength and expiry. Dose is individualized based on glucose monitoring.

Hypoglycaemia, sweating, tremor, dizziness, headache, palpitations, hunger, nausea, injection site pain/redness/swelling, lipodystrophy, weight gain, peripheral oedema, allergic reactions (rash)

Risk of severe hypoglycaemia—carry fast-acting glucose and monitor sugars regularly. Do not use if hypoglycaemia is present or if insulin appears clumped/has particles or does not become uniformly cloudy after mixing. Use caution in renal/hepatic impairment, elderly, irregular meals, increased exercise, or during illness; dose adjustments may be needed. Rotation of injection sites reduces lipodystrophy. Educate on recognition and treatment of hypoglycaemia; driving/operating machinery may be impaired during low sugar episodes.